Clinical Trial Update: Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine

View source ↗

Summary

A completed Pfizer-sponsored trial examines the reliability of rimegepant compared with triptans for acute treatment of migraine, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rimegepant (rimegepant)
• Triptans (class)

Snippet

Sponsor: Pfizer | Conditions: Migraine Disorders | Status: COMPLETED | Results posted: 2025-01-13